Your browser doesn't support javascript.
loading
Association of PTPRD/PTPRT Mutation With Better Clinical Outcomes in NSCLC Patients Treated With Immune Checkpoint Blockades.
Wang, Xiaoyan; Wu, Bingchen; Yan, Zhengqing; Wang, Guoqiang; Chen, Shiqing; Zeng, Jian; Tao, Feng; Xu, Bichun; Ke, Honggang; Li, Mei.
Afiliação
  • Wang X; Department of Respiratory Medicine, Affiliated Hospital of Nantong University, Nantong, China.
  • Wu B; Department of Oncology, Hospital of Chinese Medicine of Changxing County, Huzhou, China.
  • Yan Z; The Medical Department, 3D Medicines Inc., Shanghai, China.
  • Wang G; The Medical Department, 3D Medicines Inc., Shanghai, China.
  • Chen S; The Medical Department, 3D Medicines Inc., Shanghai, China.
  • Zeng J; Department of Thoracic Surgery, Zhejiang Cancer Hospital, University of Chinese Academy of Sciences, Hangzhou, China.
  • Tao F; Department of Respiratory Medicine, The Affiliated Hospital of Jiaxing University, Jiaxing, China.
  • Xu B; Department of Radiotherapy, Second Affiliated Hospital of Soochow University, Suzhou, China.
  • Ke H; Department of Cardiothoracic Surgery, Affiliated Hospital of Nantong University, Nantong, China.
  • Li M; Department of Medical Oncology, Affiliated Hospital of Nantong University, Nantong, China.
Front Oncol ; 11: 650122, 2021.
Article em En | MEDLINE | ID: mdl-34123798
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article